Supercharging Agriculture and Portfolios with Biostimulant Companies

WHITEFISH, MT / ACCESSWIRE / June 16, 2015 / “Biostimulants” as an agricultural input have been around
for a very long time in organic farming and gardening, but it has only been in
recent years that advances in technologies and innovation have taken root and
amplified the benefits of biostimulants to moderate impacts from pests and disease
while increasing nutrient uptake, thereby improving plant quality and yield on
a much larger scale. As such, commercial
and industrial adoption of biostimulants is spreading globally, as expressed by
the relatively new European Biostimulants Industry Council (EBIC – founded in
2011), which states that more than 3 million hectares are treated with repeated
biostimulant applications in Europe every year.

The promotion of the benefits of biostimulants has come
thanks in part to leading organizations like the ECIB and the U.S. based BioStimulant
Coalition, whose members include Arysta LifeScience and Marrone Bio Innovations
(NASDAQ: MBII). Arysta was making the
headlines last year with a potential IPO before Platform Specialty Products
(NYSE: PAH) bought them from the European private equity firm Permira for about
$3.5 billion in October, nixing the IPO shortly thereafter.

These organizations are creating awareness about
biostimulants and benefit everyone in the space, including GroGenesis (OTCQB:
GROG), the maker of a one-two punch of natural products: the biostimulant AgraBurst and the broad-spectrum
agricultural crop protection antiseptic AgraBlast.

GroGenesis has successfully tested its AgraBurst product in
the most difficult of growing conditions on various crops. From sugarcane
in Guatemala to corn
in North Carolina to wheat
in Australia and places and plants in between, such as Mexico, Thailand,
Vietnam and China, AgraBurst has been shown to improve yields across the globe.

Biostimulants represent an emerging industry expected to
experience solid growth in the near future, leaving headroom for market capture
by upstarts like Marrone and
GroGenesis. As succinctly noted in a recent GroGenesis release,
research firm MarketsandMarkets estimates the biostimulants industry will grow
at a compound annual growth rate of 12.5% to $2.5 billion by 2019, roughly in
line with the CAGR predictions for the North American market by Market
Publishers of Birmingham, U.K.

Click To
Sign Up For Future Email Updates On GroGenesis, Inc.

Looking to the crop protection market, a separate, but
synergistic business segment to the biostimulant sector, Germany-based Ceresana
Research estimates sales will be in excess of $52 billion in 2019, creating a
tremendous opportunity for the very few companies that directly target both
industries- especially with products that work together (or separately) as the
GroGenesis offering has been designed to leverage.

South America is one of the world’s biggest consumers of
crop protection products. As prolific
crop producers, South and Central American farms also deal with significant
pathogenic fungal diseases, such as coffee leaf rust and black sigatoka
impacting high value coffee and banana crops, respectively. GroGenesis has a strong hand in proving the
positive effects of AgraBurst and AgraBlast in these markets, making it a prime
initiative for the company to focus its efforts on inking distribution
agreements in these regions. As part of
this targeted initiative, the company has released white papers
on recent field trials showing the rapid action and overall efficacy of its
products to protect banana and coffee crops in Latin America, and while this
experience has proven successful, the Company claims equal effects can be produced
in a wide number of economically critical and environmentally stressed crops
around the globe.

GroGenesis is run by seasoned and successful veterans of the
agriculture industry and has attracted some top scientific, entrepreneurial and
venture capital talent, including Stuart Brazier, who serves as VP of Corporate
Development. Brazier’s resume includes
co-founding Renergy Foods AG, an
urban agriculture research and development business company.

In the video below, Mr. Brazier explains why he is
“extremely positive” about the future possibilities of AgraBurst and AgraBlast
as differentiated from other products by means of converging the biostimulant
and crop protection sectors under the umbrella of GroGenesis. He further explains why competition is
limited as GroGenesis products don’t compete with, but rather complement,
existing industries, specifically in the manner that AgraBurst enhances
fertilizer products by significantly increasing nutrient uptake while AgraBlast
protects against pathogens. A major
advantage to these products is that they are not synthetic and don’t leave any
residue or long-term effects in the soil while actually offering additional
remedial effects in many instances. The
uniqueness of these products position GroGenesis to work hand-in-hand with
fertilizer companies and existing distributors in a market predicted to
experience robust growth as the need for assured global food sources continues
to increase.

SECFilings TV Interview with Mr. Stuart Brazier / VP of Business Development at GroGenesis, Inc. (OTCQB: GROG) from TDM Financial on Vimeo.

Legal Disclaimer:

Except for the historical information
presented herein, matters discussed in this release contain forward-looking
statements that are subject to certain risks and uncertainties that could cause
actual results to differ materially from any future results, performance or
achievements expressed or implied by such statements. Emerging Growth LLC is
not registered with any financial or securities regulatory authority, and does
not provide nor claims to provide investment advice or recommendations to
readers of this release. Emerging Growth LLC may from time to time have a
position in the securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions, readers
should seek their own advice. Emerging Growth LLC may be compensated for its
services in the form of cash-based compensation or equity securities in the
companies it writes about, or a combination of the two. For full disclosure
please visit: http://secfilings.com/Disclaimer.aspx.

SOURCE: Emerging Growth LLC

ReleaseID: 429958